Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $366,574. The enterprise value is -$1.98 million.
| Market Cap | 366,574 |
| Enterprise Value | -1.98M |
Important Dates
The next estimated earnings date is Wednesday, August 14, 2024, before market open.
| Earnings Date | Aug 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 563,960 shares outstanding. The number of shares has increased by 131.59% in one year.
| Shares Outstanding | 563,960 |
| Shares Change (YoY) | +131.59% |
| Shares Change (QoQ) | +90.16% |
| Owned by Insiders (%) | 10.00% |
| Owned by Institutions (%) | 9.50% |
| Float | 204,673 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.26 |
| Quick Ratio | n/a |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -218.30% and return on invested capital (ROIC) is -273.09%.
| Return on Equity (ROE) | -218.30% |
| Return on Assets (ROA) | -146.10% |
| Return on Capital (ROIC) | -273.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$974,251 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.30% in the last 52 weeks. The beta is 1.06, so BJDX's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -98.30% |
| 50-Day Moving Average | 3.78 |
| 200-Day Moving Average | 13.87 |
| Relative Strength Index (RSI) | 27.23 |
| Average Volume (20 Days) | 687,555 |
Short Selling Information
The latest short interest is 120,047, so 21.29% of the outstanding shares have been sold short.
| Short Interest | 120,047 |
| Short Previous Month | 19,506 |
| Short % of Shares Out | 21.29% |
| Short % of Float | 58.65% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.06M |
| Pretax Income | -9.74M |
| Net Income | -9.74M |
| EBITDA | -9.07M |
| EBIT | -9.74M |
| Earnings Per Share (EPS) | -$60.80 |
Balance Sheet
The company has $2.66 million in cash and $316,514 in debt, giving a net cash position of $2.34 million or $4.16 per share.
| Cash & Cash Equivalents | 2.66M |
| Total Debt | 316,514 |
| Net Cash | 2.34M |
| Net Cash Per Share | $4.16 |
| Equity (Book Value) | 3.37M |
| Book Value Per Share | 5.97 |
| Working Capital | 1.92M |
Cash Flow
In the last 12 months, operating cash flow was -$7.68 million and capital expenditures -$398,930, giving a free cash flow of -$8.08 million.
| Operating Cash Flow | -7.68M |
| Capital Expenditures | -398,930 |
| Free Cash Flow | -8.08M |
| FCF Per Share | -$27.38 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BJDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -131.59% |
| Shareholder Yield | -131.59% |
| Earnings Yield | -2,657.72% |
| FCF Yield | -2,202.90% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |